Yahoo
OTC Markets OTCPK - Delayed Quote USD

Adhera Therapeutics, Inc. (ATRX)

0.0001 0.0000 (0.00%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for ATRX
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0085 x --
  • Ask 0.0120 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 84,001
  • Avg. Volume 312
  • Market Cap (intraday) 722
  • Beta (5Y Monthly) 826.42
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

adherathera.com

2

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ATRX
0.00%
S&P 500 (^GSPC)
7.76%

1-Year Return

ATRX
0.00%
S&P 500 (^GSPC)
9.77%

3-Year Return

ATRX
99.00%
S&P 500 (^GSPC)
68.96%

5-Year Return

ATRX
100.00%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -532.88%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -4.61M

  • Diluted EPS (ttm)

    -1.1800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    32.39k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    563.75k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: